Allergan, Inc.

2525 Dupont Drive,
Irvine, California 92623
United States,
(714) 246-4500

Allergan, Inc. is a pharmaceutical company. Allergan's products include ophthalmic pharmaceuticals, dermatology products, and neurological products.

M&A Summary

Buy vs Sell

Year ≤ '10 '11 '12 '13 '14 '15 T
Buy (1.8/yr) # 5 3 1 2 - 3 14
vol $3.5B $294M $350M $20M $2.8B $7.0B
Sell (0.6/yr) # - - - 2 - 1 3
vol $220M $40.5B $40.7B

Top M&A Advisors

Financial Deals
Sign-up to View
Legal Deals
Sign-up to View

Deal Values

> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Inamed Corp.
$3.3B (2006-03-23)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest Allergan Generics
$40.5B (2015-07-27)

Allergan was acquired by Allergan on March 17, 2015.

Allergan has acquired 17 companies of its own, including 3 in the last 5 years. A total of 8 acquisitions came from private equity firms. It has also divested 3 assets.

Allergan’s largest acquisition to date was in 2006, when it acquired Inamed for $3.3B. It’s largest disclosed sale occurred in 2015, when it sold Allergan Generics to Teva Pharmaceutical Industries for $40.5B. Allergan has acquired in 5 different US states. The Company’s most targeted sectors include medical products (43%) and life science (36%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 411 life science companies that have made at least 1 acquisition, 15 have acquired at least 5 companies, and 2 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 29 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 5 platform acquisitions.

Join Mergr and gain access to Allergan’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.4K Private Equity Firms
  • 119K M&A Transactions
  • 129K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.